Recabo, Baby Boy .
HRN: 23-45-75 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2023
CEFTAZIDIME 1GM (VIAL)
09/13/2023
09/20/2023
IV
100 Mg
Every 12 Hours
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes